Respiratory syncytial virus is the leading cause of hospitalization among U.S. infants. A vaccine, nirsevimab, can reduce the ...

So, which respiratory virus invaded your cells? Several types of viruses could be the culprit: respiratory syncytial virus ...

RSVpreF vaccination is effective against RSV-related lower respiratory tract disease among adults aged 60 years or older.

China pilots monitoring system for pneumonia of unknown origin amid rising respiratory infections, including human ...

Newsweek has created a map showing states where respiratory syncytial virus (RSV) cases are surging.

Zelpultide alfa is under clinical development by Airway Therapeutics and currently in Phase I for Coronavirus Disease 2019 (COVID-19).

Feeling ill after that Christmas or New Year's Eve party? If could be RSV. But how can you know for sure? Here are the ...